159 related articles for article (PubMed ID: 17264314)
1. Screening for increased plasma urea levels in a large-scale ENU mouse mutagenesis project reveals kidney disease models.
Aigner B; Rathkolb B; Herbach N; Kemter E; Schessl C; Klaften M; Klempt M; de Angelis MH; Wanke R; Wolf E
Am J Physiol Renal Physiol; 2007 May; 292(5):F1560-7. PubMed ID: 17264314
[TBL] [Abstract][Full Text] [Related]
2. Generation of N-ethyl-N-nitrosourea-induced mouse mutants with deviations in plasma enzyme activities as novel organ-specific disease models.
Aigner B; Rathkolb B; Klaften M; Sedlmeier R; Klempt M; Wagner S; Michel D; Mayer U; Klopstock T; de Angelis MH; Wolf E
Exp Physiol; 2009 Apr; 94(4):412-21. PubMed ID: 19151073
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel genetic loci for bone size and mechanosensitivity in an ENU mutant exhibiting decreased bone size.
Srivastava AK; Kapur S; Mohan S; Yu H; Kapur S; Wergedal J; Baylink DJ
J Bone Miner Res; 2005 Jun; 20(6):1041-50. PubMed ID: 15883645
[TBL] [Abstract][Full Text] [Related]
4. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program.
Inoue M; Sakuraba Y; Motegi H; Kubota N; Toki H; Matsui J; Toyoda Y; Miwa I; Terauchi Y; Kadowaki T; Shigeyama Y; Kasuga M; Adachi T; Fujimoto N; Matsumoto R; Tsuchihashi K; Kagami T; Inoue A; Kaneda H; Ishijima J; Masuya H; Suzuki T; Wakana S; Gondo Y; Minowa O; Shiroishi T; Noda T
Hum Mol Genet; 2004 Jun; 13(11):1147-57. PubMed ID: 15102714
[TBL] [Abstract][Full Text] [Related]
5. Large-scale albuminuria screen for nephropathy models in chemically induced mouse mutants.
Rathkolb B; Tran TV; Klempt M; Hrabé de Angelis M; Wanke R; Wolf E; Aigner B
Nephron Exp Nephrol; 2005; 100(4):e143-9. PubMed ID: 15849479
[TBL] [Abstract][Full Text] [Related]
6. Type of uromodulin mutation and allelic status influence onset and severity of uromodulin-associated kidney disease in mice.
Kemter E; Prueckl P; Sklenak S; Rathkolb B; Habermann FA; Hans W; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Wolf E; Aigner B; Wanke R
Hum Mol Genet; 2013 Oct; 22(20):4148-63. PubMed ID: 23748428
[TBL] [Abstract][Full Text] [Related]
7. Novel phenotypes identified by plasma biochemical screening in the mouse.
Hough TA; Nolan PM; Tsipouri V; Toye AA; Gray IC; Goldsworthy M; Moir L; Cox RD; Clements S; Glenister PH; Wood J; Selley RL; Strivens MA; Vizor L; McCormack SL; Peters J; Fisher EM; Spurr N; Rastan S; Martin JE; Brown SD; Hunter AJ
Mamm Genome; 2002 Oct; 13(10):595-602. PubMed ID: 12420138
[TBL] [Abstract][Full Text] [Related]
8. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
[TBL] [Abstract][Full Text] [Related]
9. Screen for alterations of iron related parameters in N-ethyl-N-nitrosourea-treated mice identified mutant lines with increased plasma ferritin levels.
Rathkolb B; Klempt M; Sabrautzki S; Michel D; Klaften M; Laufs J; Sedlmeier R; Hans W; Fuchs H; Muckenthaler MU; Horsch M; Campagna DR; Fleming M; Hrabé de Angelis M; Wolf E; Aigner B
Biometals; 2015 Apr; 28(2):293-306. PubMed ID: 25636453
[TBL] [Abstract][Full Text] [Related]
10. Two kinds of ENU-induced scant hair mice and mapping of the mutant genes.
Wu BJ; Shao YX; Mao HH; Tang D; Liu J; Xue ZF; Li HD
J Dermatol Sci; 2004 Dec; 36(3):149-56. PubMed ID: 15541636
[TBL] [Abstract][Full Text] [Related]
11. N-ethyl-N-nitrosourea mutagenesis produced a small number of mice with altered plasma electrolyte levels.
Aigner B; Rathkolb B; Klempt M; Wagner S; Michel D; de Angelis MH; Wolf E
J Biomed Sci; 2009 Jun; 16(1):53. PubMed ID: 19505327
[TBL] [Abstract][Full Text] [Related]
12. The Tennessee Mouse Genome Consortium: identification of ocular mutants.
Jablonski MM; Wang X; Lu L; Miller DR; Rinchik EM; Williams RW; Goldowitz D
Vis Neurosci; 2005; 22(5):595-604. PubMed ID: 16332270
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
15. Identification of 17 hearing impaired mouse strains in the TMGC ENU-mutagenesis screen.
Kermany MH; Parker LL; Guo YK; Miller D; Swanson DJ; Yoo TJ; Goldowitz D; Zuo J
Hear Res; 2006 Oct; 220(1-2):76-86. PubMed ID: 16949226
[TBL] [Abstract][Full Text] [Related]
16. Chemical mutagenesis induced two high bone density mouse mutants map to a concordant distal chromosome 4 locus.
Mohan S; Chest V; Chadwick RB; Wergedal JE; Srivastava AK
Bone; 2007 Nov; 41(5):860-8. PubMed ID: 17884746
[TBL] [Abstract][Full Text] [Related]
17. Generation of ENU-induced mouse mutants with hypocholesterolemia: novel tools for dissecting plasma lipoprotein homeostasis.
Aigner B; Rathkolb B; Mohr M; Klempt M; Hrabé de Angelis M; Wolf E
Lipids; 2007 Aug; 42(8):731-7. PubMed ID: 17554576
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of ENU mouse mutagenesis and archives.
Sakuraba Y; Sezutsu H; Takahasi KR; Tsuchihashi K; Ichikawa R; Fujimoto N; Kaneko S; Nakai Y; Uchiyama M; Goda N; Motoi R; Ikeda A; Karashima Y; Inoue M; Kaneda H; Masuya H; Minowa O; Noguchi H; Toyoda A; Sakaki Y; Wakana S; Noda T; Shiroishi T; Gondo Y
Biochem Biophys Res Commun; 2005 Oct; 336(2):609-16. PubMed ID: 16139793
[TBL] [Abstract][Full Text] [Related]
19. Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects.
Aigner B; Rathkolb B; Herbach N; Hrabé de Angelis M; Wanke R; Wolf E
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E232-40. PubMed ID: 18056790
[TBL] [Abstract][Full Text] [Related]
20. An ENU-induced mutation in Rs1h causes disruption of retinal structure and function.
Jablonski MM; Dalke C; Wang X; Lu L; Manly KF; Pretsch W; Favor J; Pardue MT; Rinchik EM; Williams RW; Goldowitz D; Graw J
Mol Vis; 2005 Jul; 11():569-81. PubMed ID: 16088326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
